Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Alpine Immune Sciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 58 | +3 |
| Shares | 24.7M | 1.89K | 24.0M | −713.6K (−2.9%) |
| Value | $221.8M | $17.0K | $204.4M | −$17.4M (−7.9%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Great Point Partners LLC | 538,819 | $4.58M | 1.18% |
| Western Standard LLC | 50,328 | $428.0K | 0.32% |
| Alberta Investment Management Corp | 45,906 | $391.0K | 0.00% |
| Marshall Wace, LLP | 35,930 | $305.0K | 0.00% |
| Western Wealth Management, LLC | 25,120 | $214.0K | 0.01% |
| Rhumbline Advisers | 20,404 | $174.0K | 0.00% |
| Lazard Asset Management LLC | 4,617 | $39.0K | 0.00% |
| Simplex Trading, LLC | 396 | $3.00K | 0.00% |
| Credit Suisse AG | 15 | $0 | 0.00% |
Sold out (6)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 138,279 | $1.24M |
| Tiger Management L.L.C. | 137,728 | $1.24M |
| Ensign Peak Advisors, Inc | 110,017 | $987.0K |
| Walleye Capital LLC | 41,746 | $374.0K |
| Alps Advisors Inc | 30,030 | $269.0K |
| Kingsbury Capital Investment Advisors LLC | 29,153 | $262.0K |
Not filed for Q2 2022 yet (1)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,891 | $17.0K |